(Q34847211)

English

Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Jian-Hong Zhong

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Bang-De Xiang

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Wen-Feng Gong

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Yang Ke

4

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Qin-Guo Mo

5

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Liang Ma

6

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Xing Liu

7

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Le-Qun Li

8

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

language of work or name

0 references

publication date

9 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

e68193

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

copyright license

Creative Commons Attribution 4.0 International

9 July 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706592

8 July 2018

Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706592

8 July 2018

Level of α-fetoprotein predicts mortality among patients with hepatitis C-related hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706592

8 July 2018

Applicability of the BCLC staging system to patients with hepatocellular carcinoma in Korea: analysis at a single center with a liver transplant center

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706592

8 July 2018

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706592

8 July 2018

Outcomes of hepatic resection for huge hepatocellular carcinoma (≥ 10 cm in diameter).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706592

8 July 2018

Management of hepatocellular carcinoma: An update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706592

8 July 2018

Hepatocellular carcinoma: current management and perspectives for the future

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706592

8 July 2018

Current status of radiofrequency ablation of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706592

8 July 2018

Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706592

8 July 2018

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706592

8 July 2018

Current strategy for staging and treatment: the BCLC update and future prospects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706592

8 July 2018

Hepatic resection for hepatocellular carcinoma exceeding Milan criteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706592

8 July 2018

Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706592

8 July 2018

Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706592

8 July 2018

Design and endpoints of clinical trials in hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706592

8 July 2018

Treatment of large and advanced hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706592

8 July 2018

A review of the prognostic factors in patients with recurrence after liver resection for hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706592

8 July 2018

Outcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706592

8 July 2018

Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706592

8 July 2018

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706592

8 July 2018

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706592

8 July 2018

A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706592

8 July 2018

Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706592

8 July 2018

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706592

8 July 2018

Prospective validation of the Barcelona Clinic Liver Cancer staging system

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068193

21 January 2018

Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068193

21 January 2018

Liver resection improves the survival of patients with multiple hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068193

21 January 2018

Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068193

21 January 2018

Validation of the BCLC prognostic system in surgical hepatocellular cancer patients.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068193

21 January 2018

Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068193

21 January 2018

Prediction of the risk of hepatic failure in patients with portal vein invasion hepatoma after hepatic resection

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068193

21 January 2018

Comparing hepatic resection and transarterial chemoembolization for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma: change for treatment of choice?

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068193

21 January 2018

The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068193

21 January 2018

Health-related quality of life in patients with hepatocellular carcinoma after hepatic resection, transcatheter arterial chemoembolization, radiofrequency ablation or no treatment.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068193

21 January 2018

Hepatic resection can provide long-term survival of patients with non-early-stage hepatocellular carcinoma: extending the indication for resection?

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068193

21 January 2018

A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068193

21 January 2018

Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068193

21 January 2018

Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068193

21 January 2018

Early decrease in α-fetoprotein, but not des-γ-carboxy prothrombin, predicts sorafenib efficacy in patients with advanced hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068193

21 January 2018

Prognosis of early hepatocellular carcinoma after hepatic resection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706592

26 October 2018

Outcomes of hepatic resection for a single large hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23874536

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23874536

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of surgical resection and transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria: a propensity score analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23874536

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature. A European case-control series

1 reference

https://pubmed.ncbi.nlm.nih.gov/23874536

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgical resection for advanced hepatocellular carcinoma according to Barcelona Clinic Liver Cancer (BCLC) staging

1 reference

https://pubmed.ncbi.nlm.nih.gov/23874536

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23874536

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database

1 reference

https://pubmed.ncbi.nlm.nih.gov/23874536

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23874536

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23874536

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23874536

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liver resection for complicated hepatocellular carcinoma: challenges but opportunity for long-term survivals

1 reference

https://pubmed.ncbi.nlm.nih.gov/23874536

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23874536

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgical resection of centrally located large hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23874536

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0068193

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

2013PLoSO...868193Z

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34847211&oldid=1864452857"